Winck João C, Gonçalves Miguel R, Lourenço Cristina, Viana Paulo, Almeida João, Bach John R
Pneumology Department, Hospital São João, Faculdade de Medicina, Universidade do Porto-Porto, Portugal.
Chest. 2004 Sep;126(3):774-80. doi: 10.1378/chest.126.3.774.
To analyze the physiologic effects and tolerance of mechanical insufflation-exsufflation (MI-E) for patients with chronic ventilatory failure of various etiologies.
Prospective clinical trial.
Rehabilitation unit of a university hospital.
Thirteen patients with amyotrophic lateral sclerosis (ALS), 9 patients with severe COPD, and 7 patients with other neuromuscular disorders (oNMDs) with chronic airway secretion encumbrance and decreases in oxyhemoglobin saturation (Spo(2)).
Pressures of MI-E of 15 cm H(2)O, 30 cm H(2)O, and 40 cm H(2)O were cycled to each patient, with 3 s for insufflation and 4 s for exsufflation. One application was six cycles at each pressure for a total of three applications.
We continuously evaluated respiratory inductance plethysmography (RIP) and Spo(2) during every application. Peak cough flow (PCF) and dyspnea (Borg Scale) were also measured before the first and after the last application. The technique was well tolerated in all patient groups. Median Spo(2) improved significantly (p < 0.005) in all patient groups. Median PCF improved significantly (p < 0.005) in the ALS and oNMD groups from 170 to 200 L/min and from 180 to 220 L/min, respectively, and dyspnea improved significantly in the patients with oNMDs and patients with COPD from 3 to 1 and from 2 to 0.75, respectively. Breathing pattern characteristics (RIP) did not deteriorate after MI-E in any patient groups. Inspiratory flow limitation significantly decreased at the highest MI-E pressures for the ALS group.
Our results confirm good tolerance and physiologic improvement in patients with restrictive disease and in patients with obstructive disease, suggesting that MI-E may be a potential complement to noninvasive ventilation for a wide variety of patient groups.
分析机械通气-呼气(MI-E)对各种病因导致的慢性呼吸衰竭患者的生理影响和耐受性。
前瞻性临床试验。
大学医院康复科。
13例肌萎缩侧索硬化症(ALS)患者、9例重度慢性阻塞性肺疾病(COPD)患者和7例其他神经肌肉疾病(oNMDs)患者,均有慢性气道分泌物潴留且氧合血红蛋白饱和度(Spo₂)下降。
对每位患者依次施加15 cm H₂O、30 cm H₂O和40 cm H₂O的MI-E压力,吸气3秒,呼气4秒。每个压力下进行6个周期为一次应用,共进行3次应用。
每次应用期间持续评估呼吸感应体积描记法(RIP)和Spo₂。首次应用前和最后一次应用后还测量了峰值咳嗽流量(PCF)和呼吸困难程度(Borg量表)。所有患者组对该技术耐受性良好。所有患者组的Spo₂中位数均显著改善(p < 0.005)。ALS组和oNMDs组的PCF中位数分别从170 L/min显著提高到200 L/min和从180 L/min显著提高到220 L/min(p < 0.005),oNMDs患者和COPD患者的呼吸困难程度分别从3显著改善到1和从2显著改善到0.75。在任何患者组中,MI-E后呼吸模式特征(RIP)均未恶化。在ALS组中,最高MI-E压力下吸气流量受限显著降低。
我们的结果证实,限制性疾病患者和阻塞性疾病患者对MI-E耐受性良好且生理状况得到改善,这表明MI-E可能是多种患者群体无创通气的潜在补充。